Status:

COMPLETED

Multidisciplinary Rehabilitation Programme for Breast Cancer

Lead Sponsor:

National University Hospital, Singapore

Collaborating Sponsors:

Singapore Cancer Society

Conditions:

Breast Cancer

Eligibility:

FEMALE

21-80 years

Phase:

NA

Brief Summary

The study recruits breast cancer survivors who are already on chemotherapy or are going to start chemotherapy. Subjects will be asked for their preference to attend physiotherapy and educational class...

Detailed Description

This study will be a mixed study of both quantitative and qualitative research to investigate the effect of the holistic program of combining patient education and intra chemotherapy on cancer survivo...

Eligibility Criteria

Inclusion

  • Females between 21 - 80 years old;
  • Breast cancer patients before or already on the treatment of chemotherapy, targeted therapy, and/or radiotherapy;
  • Be able to provide consent and complete questionnaires;
  • Be able to walk independently in the community without use of gait aids.
  • Breast cancer patients who are suitable for exercise.

Exclusion

  • Pregnant;
  • Uncontrolled hypertension (Resting BP \>160/90 mm Hg), or history of recurring or persistent hypotension in the past 2 months;
  • History of recent myocardial infarction or unstable angina (within the past 6 months);
  • Significant valvular disease i.e. severe aortic stenosis and moderate-severe mitral regurgitation;
  • Patient with end stage organ disease (e.g. ESRF, end stage COPD);
  • Tumor infiltration of axial or weight-bearing bones with risk of pathological fractures or compression of the spinal cord;
  • Patient with recent stroke within the past 6 months;
  • With other neuromusculoskeletal disorders such as osteoarthritis of such severity as to limit ability to participate in group exercise classes;
  • Already participating in regular physical activity (150min of moderate or 75min of vigorous physical activity/week);
  • Deemed inappropriate by primary oncologists.

Key Trial Info

Start Date :

March 17 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 21 2019

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT05306808

Start Date

March 17 2017

End Date

October 21 2019

Last Update

November 2 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Univerity Hospital

Singapore, Singapore